Cellular Pharmacology of Hyperpolarization-Relaxation Coupling

超极化弛豫耦合的细胞药理学

基本信息

  • 批准号:
    07457020
  • 负责人:
  • 金额:
    $ 4.74万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    1995
  • 资助国家:
    日本
  • 起止时间:
    1995 至 1996
  • 项目状态:
    已结题

项目摘要

The involvement of large conductance Ca^<2+>-activated K^+ channels (BK) and ATP-sensitive K^+ (K_<ATP>) channels in regulation of arterial tone was examined by measuring the change in intracellular Ca^<2+> concentration ([Ca^<2+>]_i) simultaneously with force of contraction in the canine or porcine coronary or basilar arterial smooth muscles. At resting condition, levcromakalim reduced [Ca^<2+>]_i and tone. Levcromakalim suppressed the serotonin-induced increases in [Ca^<2+>]_i and contraction, the maximum effects of which were much greater than those of nicardipine. The inhibitory effects of levcromakalim were blocked by glibenclamide but not by tetraethylammonium or iberiotoxin. Levcromakalim may reduce the Ca^<2+>-sensitivity of the contractile proteins. Thus, levcromakalim can be a candidate of therapeutic agents for delayd vasospasm after subarachnoid hemorrhage, since in the canine basilar artery levcromakalim reduces [Ca^<2+>]_i and vascular tone independently of the states of … More BK channels.The elucidation of the inhibitory of the hyperpolarization induced by K^+ chnnel openers on the Ca^<2+> movements and force of contraction produced by either the stimulation with agonists or depolarization with high KCI has shown as following : When the plasma membrane is hyperpolarized by K^+ channel openers, voltage-dependent L-type Ca^<2+> channels are deactivated and the influx of Ca^<2+> is decreased. The hyperpolarization of the plasma membrane also has another inhibitory effects on the membrane-associated enzyme activity, phospholipase C.The IP_3 production and IP_3-induced Ca^<2+> release from intracellular stores related with the stimulation of the agonist receptors are inhibited by the hyperpolarization of the plasma membrane by K^+ channel openers. The voltage-dependence of the Ca^<2+> sensitivity of contractile elements. Furthermore, membrane hyperpolarization induced by various K^+ channel openers, relaxd canine coronary arteries more profoundly than decreased [Ca^<2+>]_i.Thus, the membrane voltage may regulate intracellular enzyme activities, including contractile elements. This new facet of signal transduction therefore should be considered in the control of vascular tone. Less
通过测量细胞内Ca^<2+>浓度的变化([Ca^<2+>] _ I),仅用CORINCINE或PORCINE CORCINARE,通过测量细胞内Ca^<2+>浓度的变化来检查大型电导率Ca^<2+> - 激活的K^+通道(BK)和ATP敏感的K^+(bk)和ATP敏感的K^+(K_ <ATP>)通道参与动脉张力调节的调节。在静止条件下,levcromagalim减少了[Ca^<2+>] _ I和音调。 levcromagalim抑制了[Ca^<2+>] _ I和收缩的5-羟色胺诱导的增加,其最大作用远大于尼古丁的效果。 Levcromagalim的抑制作用被Glibenclamide封闭,而不是被四乙基氨或Iberiotoxin阻断。 Levcromagalim可能会降低收缩蛋白的CA^<2+>。 That, levcromagalim can be a candidate of therapeutic agents for delayed vasospasm after subarachnoid hemorrhage, since in the canine basilar artery levcromagalim reduces [Ca^<2+>]_i and vascular tone independently of the states of … More BK channels.The elucidation of the inhibitory of the hyperpolarisation induced by K^+ chnnel openers on the Ca^<2+>由激动剂刺激或高KCI的沉积产生的运动和收缩力如下:当质膜被K^+通道开孔器过度渗透时,电压依赖性的L型Ca^<2+>通道被取消ca^<2 <2+> <2> <2+>> <2+>降低。质膜的超极化还对与膜相关的酶活性,磷脂酶C. C. 3和IP_3诱导的Ca^<2+>从与激动剂受体刺激相关的CA^<2+>释放的磷脂酶释放也有另一种抑制作用。收缩元件的CA^<2+>敏感性的电压依赖性。此外,与先进的[Ca^<2+>] _ i.thus相比,各种K^+通道开启器,放松的犬冠状动脉诱导的膜超极化更深刻,膜电压可能调节细胞内酶活性,包括收缩元件。因此,应在血管张力的控制中考虑信号转导的新方面。较少的

项目成果

期刊论文数量(13)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
柳澤 輝行・須貝 和幸: "K^+チャネルと血管平滑筋." 脳神経外科速報,6(8) 585-589,1996.6・8. 585-589 (1996)
Teruyuki Yanagisawa 和 Kazuyuki Sugai:“K^+ 通道和血管平滑肌。”,6(8) 585-589,1996.6/8 (1996)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kurosawa H,Yanagisawa T,Taira N: "Biphacic antagonisms of β-blockers against positive introgie responses via β,adorenoceptors in iselated canine right ventricular muscle." J.Cardio vasc.Pharmacol.27. 262-268 (1996)
Kurosawa H、Yanagisawa T、Taira N:“β-受体阻滞剂通过孤立的犬右心室肌肉中的 β,肾上腺素受体对正内源反应的双相拮抗作用。J.Cardio vasc.Pharmacol.262-268。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Sugai K, Yanagisawa T, etal.: "Levcromakalim decreases aytopalasmic Ca^<2+>,vascular tone and Ca^<2+> sensitivity in canine basilar artery" Fund.Clim.Pharmacol. in press. (1998)
Sugai K、Yanagisawa T 等人:“Levcromakalim 降低犬基底动脉中的细胞浆细胞 Ca^<2>、血管张力和 Ca^<2> 敏感性”Fund.Clim.Pharmacol。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YANAGISAWA Teruyuki其他文献

YANAGISAWA Teruyuki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YANAGISAWA Teruyuki', 18)}}的其他基金

Attempt of Cancer Pain Control with the aid of Anti-TRPV Channel Antibody
借助抗TRPV通道抗体控制癌痛的尝试
  • 批准号:
    18613001
  • 财政年份:
    2006
  • 资助金额:
    $ 4.74万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular and Applied Pharmacology of Subunits of Ion Channels as Biosensors
作为生物传感器的离子通道亚基的分子和应用药理学
  • 批准号:
    10559002
  • 财政年份:
    1998
  • 资助金额:
    $ 4.74万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Molecular Pharmacology of Selective beta3-Adrenergic Receptors
选择性 β3-肾上腺素能受体的分子药理学
  • 批准号:
    07557327
  • 财政年份:
    1995
  • 资助金额:
    $ 4.74万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Studies of membrane-associated enzyme activities which are regulated by membrane potential
受膜电位调节的膜相关酶活性的研究
  • 批准号:
    05670082
  • 财政年份:
    1993
  • 资助金额:
    $ 4.74万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Mechanisms of vasodilation by K^+ channel openers
K^通道开放剂的血管舒张机制
  • 批准号:
    02670076
  • 财政年份:
    1990
  • 资助金额:
    $ 4.74万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似国自然基金

布洛芬通过线粒体超极化损伤早产儿肺血管发育的机制及干预研究
  • 批准号:
    82371707
  • 批准年份:
    2023
  • 资助金额:
    65 万元
  • 项目类别:
    面上项目
间质性肺疾病致肺气体交换功能改变的超极化129Xe MRI定量研究
  • 批准号:
    82372150
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
人参皂苷Rg1通过调控H型血管内皮细胞线粒体膜电位超极化-铁死亡拮抗糖尿病性骨质疏松症的机制研究
  • 批准号:
    82360869
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
超极化增强的固体NMR方法及在分子筛催化不饱和醛选择性加氢反应中的应用研究
  • 批准号:
    22372179
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
基于超极化13C多参数代谢成像评估肝细胞癌侵袭性的研究
  • 批准号:
    82302161
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Hyperpolarization Assisted and Structure Based Screening of Protein-Ligand Interactions in Live Cells
活细胞中蛋白质-配体相互作用的超极化辅助和基于结构的筛选
  • 批准号:
    9986546
  • 财政年份:
    2019
  • 资助金额:
    $ 4.74万
  • 项目类别:
Hyperpolarization Assisted and Structure Based Screening of Protein-Ligand Interactions in Live Cells
活细胞中蛋白质-配体相互作用的超极化辅助和基于结构的筛选
  • 批准号:
    10377569
  • 财政年份:
    2019
  • 资助金额:
    $ 4.74万
  • 项目类别:
Hyperpolarization Assisted and Structure Based Screening of Protein-Ligand Interactions in Live Cells
活细胞中蛋白质-配体相互作用的超极化辅助和基于结构的筛选
  • 批准号:
    9902528
  • 财政年份:
    2019
  • 资助金额:
    $ 4.74万
  • 项目类别:
SKca/IKca Channel Activation and Endothelial Protection During Cardiac Surgery
心脏手术期间 SKca/IKca 通道激活和内皮保护
  • 批准号:
    9919369
  • 财政年份:
    2017
  • 资助金额:
    $ 4.74万
  • 项目类别:
SKca/IKca Channel Activation and Endothelial Protection During Cardiac Surgery
心脏手术期间 SKca/IKca 通道激活和内皮保护
  • 批准号:
    9284898
  • 财政年份:
    2017
  • 资助金额:
    $ 4.74万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了